Clinical Trial Update: Infusion Laboratory: Protocol 3 (Risperidone) - 4 [Phase 1]

View source ↗

Summary

Phase 1 trial update on Risperidone (Infusion Laboratory Protocol 3) for cocaine-related disorders, sponsored by the National Institute on Drug Abuse (NIDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine-related Disorders

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 1 | Status: UNKNOWN